MedTrace Logo

OCS Liver PROTECT Continued Access Protocol

NCT04186221 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2024-07-24

Study results available
· View outcomes & findings →

Summary

Continued Access Protocol to evaluate the effectiveness of the OCS Liver System to preserve and assess donor livers.

Conditions

  • Liver Transplant

Interventions

DEVICE

OCS Liver System

OCS Liver System for preserving and assessing donor livers for transplantation

Sponsors & Collaborators

  • TransMedics

    lead INDUSTRY

Principal Investigators

  • Ahmed Elbetanony, MD · TransMedics

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-03
Primary Completion
2021-02-02
Completion
2023-02-02
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04186221 on ClinicalTrials.gov